Take Back Our Hospitals Act of 2026
Legislative Progress
Momentum (last 30 days)
2
score
0 actions · 1 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 10,940 other HR bills in the 119th — cohort avg 30d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (4)
2026 · second_quarter · Medicare/Medicaid
Issues related to healthcare and private equity, including S.4085/H.R.7920, S.3829/H.R.7537, and S.5419/H.R.10444 Issues related to the independent practice of medicine Issues related to consolidation in medicine, including S. 3822
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: Not reported · Firm income: Not reported
2026 · second_quarter · Economics/Economic Development
Issues related to healthcare and private equity, including S.4085/H.R.7920, S.3829/H.R.7537, and S.5419/H.R.10444 Issues related to the independent practice of medicine Issues related to consolidation in medicine, including S. 3822
Client expense: Not reported · Firm income: Not reported
2026 · second_quarter · Labor Issues/Antitrust/Workplace
Issues related to healthcare and private equity, including S.4085/H.R.7920, S.3829/H.R.7537, and S.5419/H.R.10444 Issues related to the independent practice of medicine Issues related to consolidation in medicine, including S. 3822
Client expense: Not reported · Firm income: Not reported
2026 · second_quarter · Health Issues
Issues related to healthcare and private equity, including S.4085/H.R.7920, S.3829/H.R.7537, and S.5419/H.R.10444 Issues related to the independent practice of medicine Issues related to consolidation in medicine, including S. 3822
Client expense: Not reported · Firm income: Not reported
2026 · third_quarter · Labor Issues/Antitrust/Workplace
Issues related to healthcare and private equity, including S.4085/H.R.7920, S.3829/H.R.7537, and S.5419/H.R.10444 Issues related to the independent practice of medicine Issues related to consolidation in medicine, including S. 3822
Client expense: Not reported · Firm income: $15,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · third_quarter · Health Issues
Issues related to healthcare and private equity, including S.4085/H.R.7920, S.3829/H.R.7537, and S.5419/H.R.10444 Issues related to the independent practice of medicine Issues related to consolidation in medicine, including S. 3822
Client expense: Not reported · Firm income: $15,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · first_quarter · Taxation/Internal Revenue Code
S.788 HOPE for Homeownership Act S. 4085 Take Back Our Hospitals Act H.R.7920 Take Back Our Hospitals Act Crypto tax policy S. 4246 Ultra-Millionaire Tax Act H.R.8085 Ultra-Millionaire Tax Act H.R. 5336 Equal Tax Act S. 4122 Equal Tax Act S. 3956 Make Billionaires Pay Their Fair Share Act H.R. 7767 Make Billionaires Pay Their Fair Share Act Carried Interest Loophole S. 4083 Working Americans' Tax Cut Act HR 7937 Working Americans' Tax Cut Act S.2818 Tax Excessive CEO Pay Act of 2025 H.R.5298 Tax Excessive CEO Pay Act of 2025 S.2845 Billionaires Income Tax Act H.R.5427 Billionaires Income Tax Act "H.R. 3140, Stop Subsidizing Multimillion Dollar Corporate Bonuses Act" S. 1576 Stop Subsidizing Multimillion Dollar Corporate Bonuses Act IRS enforcement funding Curtailing Executive Overcompensation (CEO) Act Stock buybacks Executive compensation Wealth Tax Financial Transaction Tax corporate minimum tax loophole for private equity IRS Enforcement funding
Client expense: $120,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · first_quarter · Financial Institutions/Investments/Securities
H.R. 4171, the Small Entrepreneurs Empowerment and Development (SEED) Act H.R. 6955, the Main Street Capital Access Act H.R. 7127, the Restoring Secondary Trading Market Act S. 4092 No Crypto in Social Security Act S.4157 No Bailout for Crypto Act S. 4085 Take Back Our Hospitals Act H.R.7920 Take Back Our Hospitals Act HR. 7955 BETS OFF Act S. 4115 BETS OFF Act S. 4226 Stop Trading On Predictions (STOP) Corrupt Bets Act H.R.8123 Stop Trading On Predictions (STOP) Corrupt Bets Act private equity regulation private equity in health care S. 3829 Corporate Crimes Against Health Care Act H.R. 7537 Corporate Crimes Against Health Care Act Crypto Regulatory Legislation digital assets regulation Central Bank Digital Currency H.R. 3633, the CLARITY Act (crypto market regulation) Crypto and Government Ethics, Disclosure, Constitutional issues PE and childcare H.R. 6967, the Public Company Advisory Committee Act H.R. 7085 on conflict minerals disclosures Proxy advisors H.R. 2988, Protecting Prudent Investment of Retirement Savings Act the Reward Work Act Stock buybacks Executive compensation Stock Buyback Accountability Act Insurance crisis consumer protections, supervision, and bailout policy
Client expense: $120,000 · Firm income: Not reported
2026 · second_quarter · Labor Issues/Antitrust/Workplace
Issues related to healthcare and private equity, including S.4085/H.R.7920 and S.3829/H.R.7537 Issues related to the independent practice of medicine Issues related to consolidation in medicine, including S. 3822
Client expense: Not reported · Firm income: $15,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, SENATE
2026 · second_quarter · Health Issues
Issues related to healthcare and private equity, including S.4085/H.R.7920 and S.3829/H.R.7537 Issues related to the independent practice of medicine Issues related to consolidation in medicine, including S. 3822
Client expense: Not reported · Firm income: $15,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, SENATE
2026 · second_quarter · Health Issues
Issues related to out of pocket costs. S. 3822 - Break Up Big Medicine Act - in support. S.4085 - Take Back Our Hospitals Act of 2026. H.R.7920 - Take Back Our Hospitals Act of 2026. S.2355 - Patients Deserve Price Tags Act - in support.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · first_quarter · Taxation/Internal Revenue Code
S.788 HOPE for Homeownership Act S. 4085 Take Back Our Hospitals Act H.R.7920 Take Back Our Hospitals Act Crypto tax policy S. 4246 Ultra-Millionaire Tax Act H.R.8085 Ultra-Millionaire Tax Act H.R. 5336 Equal Tax Act S. 4122 Equal Tax Act S. 3956 Make Billionaires Pay Their Fair Share Act H.R. 7767 Make Billionaires Pay Their Fair Share Act Carried Interest Loophole S. 4083 Working Americans' Tax Cut Act HR 7937 Working Americans' Tax Cut Act S.2818 Tax Excessive CEO Pay Act of 2025 H.R.5298 Tax Excessive CEO Pay Act of 2025 S.2845 Billionaires Income Tax Act H.R.5427 Billionaires Income Tax Act "H.R. 3140, Stop Subsidizing Multimillion Dollar Corporate Bonuses Act" S. 1576 Stop Subsidizing Multimillion Dollar Corporate Bonuses Act IRS enforcement funding Curtailing Executive Overcompensation (CEO) Act Stock buybacks Executive compensation Wealth Tax Financial Transaction Tax corporate minimum tax loophole for private equity IRS Enforcement funding
Client expense: $150,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · first_quarter · Financial Institutions/Investments/Securities
H.R. 4171, the Small Entrepreneurs Empowerment and Development (SEED) Act H.R. 6955, the Main Street Capital Access Act H.R. 7127, the Restoring Secondary Trading Market Act S. 4092 No Crypto in Social Security Act S.4157 No Bailout for Crypto Act S. 4085 Take Back Our Hospitals Act H.R.7920 Take Back Our Hospitals Act HR. 7955 BETS OFF Act S. 4115 BETS OFF Act S. 4226 Stop Trading On Predictions (STOP) Corrupt Bets Act H.R.8123 Stop Trading On Predictions (STOP) Corrupt Bets Act private equity regulation private equity in health care S. 3829 Corporate Crimes Against Health Care Act H.R. 7537 Corporate Crimes Against Health Care Act Crypto Regulatory Legislation digital assets regulation Central Bank Digital Currency H.R. 3633, the CLARITY Act (crypto market regulation) Crypto and Government Ethics, Disclosure, Constitutional issues PE and childcare H.R. 6967, the Public Company Advisory Committee Act H.R. 7085 on conflict minerals disclosures Proxy advisors H.R. 2988, Protecting Prudent Investment of Retirement Savings Act the Reward Work Act Stock buybacks Executive compensation Stock Buyback Accountability Act Insurance crisis consumer protections, supervision, and bailout policy
Client expense: $150,000 · Firm income: Not reported
2026 · first_quarter · Labor Issues/Antitrust/Workplace
Issues related to healthcare and private equity, including S.4085/H.R.7920 and S.3829/H.R.7537 Issues related to the independent practice of medicine Issues related to consolidation in medicine, including S. 3822
Client expense: Not reported · Firm income: $15,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · first_quarter · Health Issues
Issues related to healthcare and private equity, including S.4085/H.R.7920 and S.3829/H.R.7537 Issues related to the independent practice of medicine Issues related to consolidation in medicine, including S. 3822
Client expense: Not reported · Firm income: $15,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · first_quarter · Health Issues
H.R. 4581 / S.2372, 340B PATIENTS Act, all provisions; H.R. 3178 / S. 1600, The Save Healthcare Workers Act, all provisions; H.R. 929 / S. 266, Dr. Lorna Breen Health Care Provider Protection Reauthorization Act, all provisions; H.R. 1585 / S. 709, Conrad State 30 and Physician Access Reauthorization Act, all provisions; S. 1874, Title VIII Nursing Workforce Reauthorization Act, all provisions; S. 2169, Rural, Hospital Cybersecurity Enhancement Act, all provisions; H.R. 5283 / S. 2759, Healthcare Workforce Resilience Act, all provisions; S. 3315, Health Care Cybersecurity and Resiliency Act of 2025, all provisions; H.R. 5256, 340B Access Act, all provisions; S. 1929, SEPSIS Act, all provisions; S. 2355 / H.R. 5582, Patients Deserve Price Tags Act, all provisions; H.R. 7961, Physicians and the Healthcare Workforce Act, all provisions; S. 3435 / H.R. 6607, The Future Advancement of Academic Nursing, all provisions; H.R. 5428, Medical Student Education Authorization Act of 2025, all provisions; H.R. 7920 / S. 4085, Take Back Our Hospitals Act, all provisions; S. 4208, A bill to establish a demonstration program to provide payments on eligible loans for individuals who are eligible for the National Health Service Corps Loan Repayment Program, all provisions; DRAFT, Conrad 30 Enhancement Bill, all provisions; DRAFT, Rural Maternity Bill, all provisions; S.3788, Consumer Labeling for Enhanced API Reporting and Legitimate Accountability for Base Entity Listings Act, all provisions; S.3822, Break Up Big Medicine Act, all provisions; H.R.7727, Sustaining Rural Healthcare Act, all provisions; DRAFT, Preserving Patient Access Act, all provisions; H.R. 5629, Medications for the Treatment of Opioid Use Disorder (OUD), all provisions; S. 4141, Rural Hospital Revitalization Act of 2026, all provisions; H.R. 7478, Patient Debt Relief Act, all provisions; Federal Trade Commission, Issue pertaining to the remarks at the forge Mason Law Review 29th Annual Antitrust Symposium; Department of Health & Human Services / Office of the National Coordinator for Health IT, Issues pertaining to Health Data, Technology and Interoperability; Health Resources and Services Administration (HRSA), Comments pertaining to Eli Lilly and Company policy and impact to 340B hospitals; Health Resources and Services Administration (HRSA), Comments pertaining to Novo Nordisk policy and impact to 340B hospitals; Health Resources and Services Administration (HRSA), Comments pertaining to the request for information on a new 340B rebate model program; Department of Health & Human Services / Office of the National Coordinator for Health IT, Issues pertaining to diagnostic imaging interoperability; U.S. Department of Education, Issues pertaining to proposed rule implementing borrowing limits for federal student loans and impact on health care workforce; U.S. Department of Health & Human Services (HHS), Issues pertaining to accelerating the adoption and use of AI as part of clinical care; Enhanced Premium Tax Credits, Extension of Enhanced Premium Tax Credits; Rural Health Care Access, Issues to protect access to rural health care; 340B Program, Issues pertaining to protecting 340B Program, including 340B Rebate Model Pilot Program; Maternal and Child Health, Access to maternal and child health care and addressing related workforce shortages, conditions of participation (COP); Behavioral Health, Issues related to expanding access to care and reducing regulatory barriers; Workforce, Issues pertaining to workforce development programs, supporting health care workforce and physician shortages, definitions of professional degree programs and borrowing limits, loan repayment programs for providers in rural and underserved areas, Graduate Medical Education program; Health Plan Accountability, Issues specific to prior authorization, patient access to care, adequate provider networks, inappropriate denials, reducing account receivables, prompt pay, white-bagging and brown-bagging policies; Health Care Resiliency & Preparedness, Issues pertaining to natural disasters, strengthen health care cybersecurity, cybersecurity workforce, and securing drug supply chains, hospital preparedness program, PAHPA reauthorization, outstanding FEMA COVID payments to hospitals; Price Transparency, Issues related to hospital price transparency; Affordability, Issues pertaining to the cost of health care; Tax-exempt status, Issues pertaining to not-for-profit hospitals' tax exempt status and tax-exempt private activity bonds; Immigration, Proposed H1-B Visa Program changes and impact to health care workforce; AI in Healthcare, Issues pertaining to the use of AI in healthcare.
2026 · first_quarter · Health Issues
Issues related to out of pocket costs. S. 3822 - Break Up Big Medicine Act - in support . S.4085 - Take Back Our Hospitals Act of 2026. H.R.7920 - Take Back Our Hospitals Act of 2026.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
| Democratic |
| MN |
| Jesús G. "Chuy" García | Democratic | IL |
| Madeleine Dean | Democratic | PA |
| Pramila Jayapal | Democratic | WA |
| Rashida Tlaib | Democratic | MI |
| Rosa L. DeLauro | Democratic | CT |
| Seth Moulton | Democratic | MA |
| Shri Thanedar | Democratic | MI |
| Stephen F. Lynch | Democratic | MA |
| Summer L. Lee | Democratic | PA |
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Client expense: $6,080,000 · Firm income: Not reported
Government targets: Education, Dept of, Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE